A detailed history of Principal Securities, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Principal Securities, Inc. holds 50 shares of NEO stock, worth $769. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Previous 150 66.67%
Holding current value
$769
Previous $2.08 Million 64.54%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$13.4 - $17.73 $1,340 - $1,773
-100 Reduced 66.67%
50 $738,000
Q2 2024

Jul 31, 2024

SELL
$13.01 - $15.77 $1,951 - $2,365
-150 Reduced 50.0%
150 $2.08 Million
Q4 2023

Feb 07, 2024

BUY
$11.67 - $20.73 $3,501 - $6,219
300 New
300 $4.85 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.94B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.